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were less likely to receive thrombolytic therapy, beta-
blockers or undergo angiography and had higher
mortality.
http://dx.doi:10.1016/j.jsha.2013.03.167
Prognostic significance of high sensitivity C-reac-
tive protein in patients with angina pectoris und-
erwent percutaneous coronary intervention
Tayeb Bafadhel, Yehia Kishk, Amr Yousef
Background: C-reactive protein is an easily measur-
able acute phase reactant synthesized by hepatocytes in
response to pro-inflammatory cytokines. Elevated CRP
has been identified as a strong predictor of prognosis in
healthy individuals, in patients with stable angina, in
unstable angina and in patients after acute myocardial
infarction. The prognostic significance of high sensitivity
CRP level in percutaneous coronary intervention is
unclear.
Methods: We prospectively studied 41 patients with
chronic stable angina (28 patients) and unstable angina
(13 patients) who underwent elective coronary stenting.
All patients had normal troponin level before the proce-
dure. Blood samples for hs_CRP were obtained before
the procedure, 24 h after the procedure. Patients followed
up at 1 month and after 2 years.
Results: Mean hs_CRP before the procedure in all
patients underwent PCI was 2.38 ± 2.21 lg/ml. The mean
hs_CRP 24 h post procedure was 7.43 ± 10.6 lg/ml. There
was significant difference between pre procedural hs-
CRP and 24 h post procedural (P = 0.007) At follow up
period (1 month), No major adverse cardiac events
(MACE) have occurred. However, 24 patients complain
of chest pain. There was no significant correlation
between either pre-procedural, or 24 h post procedure
hs-CRP and chest pain (r = 0.13, 0.2, respectively). At fol-
low up period (2 years), 7 cases missed; MACE has
occurred in 13 patients.
Conclusion: Mechanical disruption of atheroscle-
rotic plaque during elective coronary stent implantation
causes a systemic inflammatory response. Measuring of
hs-CRP either pre-procedural or post procedural in low
risk patients is not useful for predicting of either early
or late cardiovascular events.
http://dx.doi:10.1016/j.jsha.2013.03.168
Bentall procedure for adult patient with supraval-
vular aortic stenosis and coronary aneurysms
Haytham Al-Zahrani, Mostafa Al-Shumairy,
Hanan Al-Backr, Bakir Bakir, Raed Al-Satli, Turki
B. Albacker
We report a complex case of a 35-year-old gentleman
who presented with large anterior myocardial infarction.
Coronary angiography showed multiple coronary aneu-
rysms of all proximal major coronaries with a total occlu-
sion of the LAD artery. A diffuse form of supravalvular
aortic stenosis was discovered incidentally upon aortic
root injection and was confirmed with CT aortogram.
Echocardiography revealed akinesia of the anterior
wall with preserved thickness and depressed left ventric-
ular function (EF = 25%). Aortic valve was competent
with normal leaflet structure. The patient underwent
Bentall procedure with LIMA to LAD coronary bypass
grafting with the use of cardiopulmonary bypass utilizing
the right axillary artery for arterial cannulation and rou-
tine right atrial venous cannulation. The post-operative
course was uneventful. The patient was discharged home
after 7 days and came back for follow up after 6 months
in good condition.
http://dx.doi:10.1016/j.jsha.2013.03.169
Total occlusion, basic equipments for lesion inter-
rogation, evaluation, visualization and endolumi-
nal reopening study
Waleed Y. Kadro, Maya Turkmani, Hussam
Rahim, Owais Altisheh
Background: Chronic total occlusion (CTO) is a chal-
lenging dilemma for the interventional cardiologist. The
success rate ranges between 30% and 80% depending
on the tools used and the patience of the interventional
cardiologist who should always be ready for the unex-
pected. We report our results for CTO intervention using
simple and economic tools.
Method: Our group did 472 consecutive cases of
CTO intervention over the past seven years using the
simple approach. The tools consist of one guiding cathe-
ter, one stiff hydrophilic glide wire, one balloon and one
stent in most cases unless the lesion is too long requiring
more than one stent. Contra lateral injection to assess the
collaterals was not allowed in this basic equipments pro-
tocol for CTO intervention. 57% of the cases were turned
down for PCI by other cardiologists (group1). CTsur-
geons turned down 37% of the patients for CABG
(group2). 20.42% of the cases failed attempted PCI by
another cardiologists (group3).
Results: Overall angiographic success with TIMI II–
III flow and no significant residual stenosis was achieved
in 91% of the cases. There were no death or emergency
CABG during hospital stay or one month after PCI. Pro-
tocol violation (usage of more than one wire or more than
one balloon) was done in 10 cases. Perforation occurred
in 5 (1.12%) cases, two of them required pericardial win-
dow. In hospital MI occurred in 6 cases (1.24%). There
was no need for GP IIb/IIIa inhibitors in any case. Suc-
cess rate were 87%, 91%, 100% in groups 1, 2, 3, respec-
tively. One month follow up results were: 0% mortality,
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0% CABG, 0% reintervention, 2% rehospitalization for
CHF, 1.4% rehospitalization for ACS.
Conclusion: CTO requires endless patience from the
cardiologist. There is no need to abuse the resources of
the cath lab if we follow the protocol of TO BELIEVERS.
Excellent results can be obtained if CTO intervention
done by using these basic equipments.
http://dx.doi:10.1016/j.jsha.2013.03.170
Statin and ezetimibe in silent ambulatory myocar-
dial ischemia (sesami trial)
Waleed Y. Kadro, Maya Turkmani, Hussam
Rahim, Owais Altisheh, Ali Debs
Background: Cholesterol lowering is associated with
a reduction in cardiovascular morbidity and mortality.
Statins are the main drugs for cholesterol lowering. Eze-
timibe when added to statins gives further reduction in
cholesterol but its long-term effect on cardiovascular
morbidity and mortality and ischemic events is not
known. This study sought to determine whether further
cholesterol lowering with ezitimibe will also results in a
reduction of myocardial ischemia during daily life.
Methods: We enrolled 50 patients with proven stable
coronary artery disease (CAD) and at least one episode of
ST-segment depression on ambulatory ECG monitoring.
All of them were receiving optimal therapy for CAD
including statin therapy for cholesterol reduction. 25
patients were randomized to continue their statin ther-
apy (Statin only group) and 25 to recieve statin plus ezi-
timibe 10 mg/day (ezitimibe group). Serum cholesterol
and LDL cholesterol levels and ambulatory monitoring
were repeated after 4–6 months of therapy. The two
groups were comparable with respect to baseline charac-
teristics, number of episodes of ST-segment depression,
and baseline serum cholesterol levels. Holters were read
by a blinded cardiologist.
Results: The ezitimibe group had lower mean total
and LDL cholesterol levels at study end and experienced
a significant reduction in the number of episodes of ST-
segment depression compared with the statin only
group. ST-segment depression was completely resolved
in 13 of 25 patients (52%) in the ezitimibe group versus
3 of 25 (12%) in the statin only group. The ezitimibe group
exhibited a highly significant reduction in ambulatory
ischemia (P < .001). By logistic regression, treatment with
ezitimibe was an independent predictor of ischemia
resolution.
Conclusions: Further cholesterol lowering with ezi-
timibe can result in reduction or resolution of myocardial
ischemia recorded as episodes of ST-segment depression
in ambulatory monitoring of the ECG.
http://dx.doi:10.1016/j.jsha.2013.03.171
Troponin level before coronary artery bypass graft
surgery is associated with increased mortality rate
Walid Abukhudair, Massimo Porqueddo,
Nazir Ahmed, Ahmed Hafed, Abdullah Ashmeg,
Thamer Bin Yousef
Objective: Cardiac troponin level indicate extend of
miocardial injury.
Coronary artery bypass graft surgery early post myo-
cardial infartion is associated with high mortality, trying
to find a quantitative piameter to determine the high risk
patients.
Method: Prospective data collection of troponin level
and outcome of coronary artery bypass graft surgery was
collected over 3 years (30 days mortality).
Result: A total of 550 patients who had CABG over
3 years was collected, the patients were divided into 3
groups. Group 1 patient with troponin less than 3. Group
2 patient with troponin between 3 and 5. Group 3 patient
with troponin above 5. The 30 days mortality was propor-
tionally correlated to the troponin level. Group 1 had a
mean mortality of less than 2%, group 2 had a mean mor-
tality of 3.5%, and group 3 had a mean mortality rate of
10%.
Conclusion: Preoperative 30 days mortality post
CABG is proportionally related to the extend of myocar-
dial damage which is reflected by trop in level. When
possible it is better to wait and delay surgery until tropo-
nin level below 3.
http://dx.doi:10.1016/j.jsha.2013.03.172
Proper method for preoperative chest preparation
of patients listed for cardiac surgery
Walid Abdulkarim Abukhudair
Context: Postoperative pulmonary complication
(PCCs) after cardiac surgery are a major source of mor-
bidity and mortality, and increase length of hospital stay
and resource utilization. The preoperative including pre-
hospitlization period before CARDIAC surgery maybe
used to improve a patients pulmonary condition. The
efficacy of preoperative non-invasive CPAP and BIPAP
machine use, chest physiotherapy (CPT) and postural
drainage, frequent nebulization plus inspiratory muscle
training (IMT) in reducing the incidence of PPCs in
high-risk patients undergoing CARDIAC surgery has
not yet been determined.
Objective: To evaluate the prophylactic efficacy of
our new preoperative chest preparation strategy (strategy
A) on the incidence of PPCs in high risk patients sched-
uled for elective CARDIAC surgery compared with clas-
sic routinely used one (Strategy B).
Design, setting, and patients: A single blind,
randomized clinical trial conducted at the Cardiac
Center of Kind Fahad Armed forces Hospital, Jeddah,
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